Global Genomic Biomarkers Market 2020-2026 Sets the Table for Continued Growth | Global Players - F. Hoffmann-La Roche Ltd, Myriad Genetics, Inc, Eurofins Scientific, QIAGEN, Bio-Rad Laboratories

A detailed study on Global Genomic Biomarkers Market' formulated by Data Bridge Market Research, puts together a concise analysis of the growth factors impacting the current business scenario across assorted regions. Significant information pertaining to the industry's size, share, application, and statistics are also summed in the report in order to present an ensemble prediction. In addition, this report undertakes an accurate competitive analysis illustrating the status of market majors in the projection timeline, while including their expansion strategies and portfolio. Some of the major and emerging players in the Global Genomic Biomarkers Market are Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Myriad Genetics, Inc, Eurofins Scientific, QIAGEN, Bio-Rad Laboratories, Inc., MedGenome, Almac Group, Transgenomic Ltd, Sema4., GENOME LIFE SCIENCES, Creative Diagnostics, Cancer Genetics Inc., FOUNDATION MEDICINE, INC. CENTOGENE AG,, Quanterix., and others

Global genomic biomarkers market is set to witness a healthy CAGR of 17.65% in the forecast period of 2019- 2026. The report contains data of the base year 2018 and historic year 2017. Increasing cases of colorectal cancer and rising awareness about benefit of biomarker to treat fatal diseases are the major factor for the growth of this market.

Download Sample Copy of Report Along with Graphs & Charts@ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-genomic-biomarkers-market

Key Developments in the Market:

In September 2018, Cancer Genetics, Inc. and NovellusDx, Ltd announced that they have signed an agreement according to which they are going to merge so that they can combine their data set and test portfolio associated to tumor biology. The main aim of the acquisition is to expand their therapeutic development and provide better treatment to the patient and biopharma companies

In February 2015, Roche announced that they have acquired Signature Diagnostics AG so that they can advance their translational research for their generating sequencing diagnostics. The main aim of the acquisition is to develop their NGS assays using cfDNA so that they can create non- invasive treatment for cancer patients

Market Drivers

Increasing demand for minimally invasive procedure will drive the market

Technological advancement and development in clinical laboratory tests will propel market

Increasing cases gastric and ovarian cancer will also act as a driver for this market

Rising demand for genomic biomarker based medicine will also contribute as a factor for the growth of this market

Market Restraints

Difficulty related with the process of genomics biomarker will also restrain the market

Strict government regulation will also restrain the growth of this market

Access Full Report @ https://www.databridgemarketresearch.com/reports/global-genomic-biomarkers-market

Segmentation:Global Genomic Biomarkers Market

By Application

Oncology

Cardiovascular diseases

Neurological diseases

Others

By End- User

Diagnostic and research laboratories

Hospitals

Others

By Geography

North America

South America

Europe

Middle East and Africa

Inquiry For Customize Report With Discount at :https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-genomic-biomarkers-market

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: Sopan.gedam@databridgemarketresearch.com

About Us:

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune. We ponder into the heterogeneous markets in accord with our clients needs and scoop out the best possible solutions and detailed information about the market trends. Data Bridge delve into the markets across Asia, North America, South America, Africa to name few.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

This release was published on openPR.